These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4588903)

  • 21. Treatment of severe combined immunodeficiency with bone-marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor.
    Horowitz SD; Bach FH; Groshong T; Hong R; Yunis EJ
    Lancet; 1975 Sep; 2(7932):431-3. PubMed ID: 51239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic marrow grafts in man using cyclophosphamide.
    Santos GW; Sensenbrenner LL; Burke PJ; Mullins GM; Anderson PN; Tutschka PJ; Braine HG; Davis TE; Humphrey RL; Abeloff MD; Bias WB; Borgaonkar DS; Slavin RE
    Transplant Proc; 1974 Dec; 6(4):345-8. PubMed ID: 4155151
    [No Abstract]   [Full Text] [Related]  

  • 23. Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency.
    De Koning J; Van Bekkum DW; Dicke KA; Dooren LJ; Rádl J; Van Rood JJ
    Lancet; 1969 Jun; 1(7608):1223-7. PubMed ID: 4182410
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone-marrow transplantation from an HL-A non-identical but mixed-lymphocyte-culture identical donor.
    Lancet; 1973 May; 1(7813):1146-50. PubMed ID: 4123539
    [No Abstract]   [Full Text] [Related]  

  • 25. Hereditary thymic dysplasia: a graft-versus-host reaction induced by bone marrow cells with a partial 4a series histoincompatibility.
    Kretschmer R; Jeannet M; Mereu TR; Kretschmer K; Winn H; Rosen FS
    Pediatr Res; 1969 Jan; 3(1):34-40. PubMed ID: 4885730
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on non HL-A cytotoxic and blocking factor in a patient with immunological deficiency successfully reconstituted by bone marrow transplantation.
    Jeannet M; Rubinstein A; Pelet B
    Tissue Antigens; 1973; 3(6):411-6. PubMed ID: 4130126
    [No Abstract]   [Full Text] [Related]  

  • 27. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress in the treatment and prevention of secondary disease after homologous bone marrow transplantation in monkeys. Effects of chemotherapy and of donor selection by histocompatibility testing.
    van Putten LM; Balner H; Muller-Bérat CN; de Vries MJ; van Bekkum DW
    Bibl Haematol; 1968; 29():574-86. PubMed ID: 4973299
    [No Abstract]   [Full Text] [Related]  

  • 29. T- and B-cell chimerism in two patients with severe combined immunodeficiency (SCID) after transplantation.
    Griscelli C; Durandy A; Ballet JJ; Prieur AM; Hors J
    Transplant Proc; 1977 Mar; 9(1):171-5. PubMed ID: 325757
    [No Abstract]   [Full Text] [Related]  

  • 30. Minnesota experience in bone-marrow transplantation in man, 1968 to June 1973.
    Park BH; Biggar WD; Good RA
    Transplant Proc; 1974 Dec; 6(4):379-83. PubMed ID: 4280164
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency].
    Yamagami M; Matsuda A; Nakarai T; Katayama K; Saigawa Y; Horita S; Miura M; Kato E; Koizumi S; Taniguchi N
    Rinsho Ketsueki; 1987 Sep; 28(9):1669-74. PubMed ID: 3325660
    [No Abstract]   [Full Text] [Related]  

  • 32. Uncomplicated HL-A matched sibling bone marrow graft for combined immune deficiency.
    Yamamura M; Newton RC; James DC; Humble JG; Butler LJ; Hobbs JR
    Br Med J; 1972 Apr; 2(5808):265-9. PubMed ID: 4553813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe combined immunodeficiency and adenosine deaminase deficiency.
    Parkman R; Gelfand EW; Rosen FS; Sanderson A; Hirschhorn R
    N Engl J Med; 1975 Apr; 292(14):714-9. PubMed ID: 1089883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic reconstititution of a patient with combined immunodeficiency disease.
    Biggar WD; Good RA; Park BH
    J Pediatr; 1972 Aug; 81(2):301-6. PubMed ID: 4402890
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic prospects in severe primary immune deficiency].
    Seligmann M; Weisgerber C
    Presse Med (1893); 1970 Feb; 78(8):357-8. PubMed ID: 4907367
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe combined immunodeficiency treated with bone marrow graft.
    Robinson JE
    Proc R Soc Med; 1975 Sep; 68(9):583-4. PubMed ID: 1105600
    [No Abstract]   [Full Text] [Related]  

  • 37. Selection of related and unrelated bone marrow donors.
    Goldmann SF
    Transplant Proc; 1977 Mar; 9(1):507-11. PubMed ID: 17197
    [No Abstract]   [Full Text] [Related]  

  • 38. Fine structure of thymus after bone marrow transplantation in an infant with severe combined immunodeficiency.
    Bockman DE; Lawton AR; Cooper MD
    Lab Invest; 1972 Mar; 26(3):227-39. PubMed ID: 4552617
    [No Abstract]   [Full Text] [Related]  

  • 39. A compendium of reported human bone marrow transplants.
    Bortin MM
    Transplantation; 1970 Jun; 9(6):571-87. PubMed ID: 4911417
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphoid chimerism after allogeneic bone marrow transplantation. Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins.
    Korver K; de Lange GG; van den Bergh RL; Schellekens PT; van Loghem E; van Leeuwen F; Vossen JM
    Transplantation; 1987 Nov; 44(5):643-50. PubMed ID: 3318034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.